Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 80.08% is in line with its 2-year average of 76.97%, near the high end of its 2-year range (72.36%–83.00%).
1.44% above its 12-month average of 78.94%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 83.00%.
GROSS MARGIN
80.08%
GROSS MARGIN AVG TTM
78.94%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.44%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+93.52%
vs the sector median at left
Heartflow, Inc. Common Stock
Market Cap
$4.37B
Gross Margin
80.08%
TTM Avg
78.94%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.31B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.31B
Gross Margin
75.44%
TTM Avg
66.98%
3Y Avg
64.58%
5Y Avg
67.25%
Market Cap
$4.48B
Gross Margin
83.86%
TTM Avg
80.36%
3Y Avg
82.01%
5Y Avg
82.83%
Market Cap
$4.60B
Gross Margin
71.27%
TTM Avg
60.67%
3Y Avg
48.49%
5Y Avg
48.49%
Market Cap
$4.11B
Gross Margin
76.83%
TTM Avg
-1487.68%
3Y Avg
-5412.33%
5Y Avg
-4507.64%
Market Cap
$4.64B
Gross Margin
18.17%
TTM Avg
19.16%
3Y Avg
20.78%
5Y Avg
21.38%
Market Cap
$4.70B
Gross Margin
33.56%
TTM Avg
32.27%
3Y Avg
30.18%
5Y Avg
31.09%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heartflow, Inc. Common Stock (HTFL) | $4.37B | 80.08% | 78.94% | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.31B | 0.00% | 0.00% | 0.00% | 0.00% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.31B | 75.44% | 66.98% | 64.58% | 67.25% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.48B | 83.86% | 80.36% | 82.01% | 82.83% |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 71.27% | 60.67% | 48.49% | 48.49% |
| LivaNova PLC (LIVN)vs › | $4.12B | 68.18% | 68.59% | 68.31% | 67.52% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.11B | 76.83% | -1487.68% | -5412.33% | -4507.64% |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 18.17% | 19.16% | 20.78% | 21.38% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 33.56% | 32.27% | 30.18% | 31.09% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.02B | 61.64% | 80.82% | 86.99% | 87.36% |
Gross Margin
80.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 83.00% |
| 2026-03-31 | 80.18% |
| 2025-12-31 | 79.51% |
| 2025-09-30 | 76.53% |
| 2025-06-30 | 75.48% |
| 2025-03-31 | 75.10% |
| 2024-12-31 | 75.05% |
| 2024-09-30 | 75.72% |
| 2024-06-30 | 76.77% |
| 2024-03-31 | 72.36% |
